5.0
30. Juni 2021
Aktueller Mitarbeiter
San Francisco, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Fast moving Doing some really revolutionary stuff First team in biotech software that actually knows what they are doing when it comes to biotech software.
Kontras
Small startup Does not pay too much without taking equity into account.